Yan-hong Chen

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients

Jiye Yin, Han Yan, Xiao-Qing Yuan, 2016, Oncotarget.

Under explored epigenetic modulators: role in glioma chemotherapy

Q. Cheng, Xiaoping Chen, Yan-hong Chen, 2018, European journal of pharmacology.

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas

Jie Zhao, Q. Cheng, Xiaolei Hu, 2018, Cellular Physiology and Biochemistry.

Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kα-selective inhibitor CYH33 in breast cancer.

Yi Chen, Jian Ding, Ling-hua Meng, 2018, Cancer letters.

Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux

Q. Cheng, Jie-ya Wang, He Li, 2019, Journal of experimental & clinical cancer research : CR.

Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas

Jie Zhao, Q. Cheng, Jie-ya Wang, 2020, Journal of cellular and molecular medicine.

Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux

Q. Cheng, Jie-ya Wang, He Li, 2019, Journal of Experimental & Clinical Cancer Research.